Craneware plc (AIM:CRW)

London flag London · Delayed Price · Currency is GBP · Price in GBX
1,530.00
-28.00 (-1.80%)
Apr 28, 2026, 4:35 PM GMT
-8.93%
Market Cap 537.03M
Revenue (ttm) 157.02M
Net Income (ttm) 16.70M
Shares Out 34.47M
EPS (ttm) 0.47
PE Ratio 33.39
Forward PE 16.40
Dividend 0.34 (2.15%)
Ex-Dividend Date Mar 19, 2026
Volume 343,449
Average Volume 252,498
Open 1,550.00
Previous Close 1,558.00
Day's Range 1,520.00 - 1,564.00
52-Week Range 1,272.34 - 2,644.00
Beta -0.20
RSI 59.75
Earnings Date May 29, 2026

About Craneware

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. It provides solutions, such as Trisus Pricing Analyzer and Transparency, a solution that optimizes and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity requirements; Trisus Claims Informatics, a retrospective charge capture analytical application; Trisus Supply, a solution tha... [Read more]

Industry Medical - Healthcare Information Services
Sector Healthcare
Founded 1999
Employees 765
Stock Exchange London Stock Exchange AIM
Ticker Symbol CRW
Full Company Profile

Financial Performance

In fiscal year 2025, Craneware's revenue was $205.66 million, an increase of 8.66% compared to the previous year's $189.27 million. Earnings were $19.66 million, an increase of 68.02%.

Financial numbers in USD Financial Statements

News

Craneware Earnings Call Transcript: H1 2026

Delivered 6% revenue growth and 10% adjusted EBITDA increase, with ARR reaching $184.2 million and NRR at 103%. New AI-enabled products and strong customer retention underpin confidence in continued expansion, despite 340B program uncertainty.

2 months ago - Transcripts

Craneware Earnings Call Transcript: H2 2025

Revenue grew 9% to $205.7M and adjusted EBITDA rose 12% to $65.3M, with strong recurring revenue and high customer retention. Strategic investments in R&D, a new Microsoft partnership, and robust capital allocation underpin confidence in future growth.

8 months ago - Transcripts